Introduction
============

Human parturition is widely accepted as an inflammatory process initiated by environmental, endocrine, and physiological factors, although the precise mechanisms involved are still unclear ([@B14]; [@B33]). Normal term parturition consists of well-orchestrated events involving both fetal and maternal compartments ([@B5]; [@B11]). On the maternal side, activation of the decidua, myometrial functional progesterone withdrawal, and cervical ripening are all considered mechanistic signals associated with parturition ([@B40]; [@B35]). Both endocrine and paracrine fetal biochemical signals released from matured organs, such as increased cortisol production by fetal adrenals or surfactant protein-A from fetal lungs, can induce parturition ([@B19]; [@B11]; [@B33]; [@B22]). Our laboratory has investigated a new fetal signaling mechanism initiated by fetal membrane senescence in response to inflammation and oxidative stress that builds up in the amniotic cavity at term ([@B20]; [@B23], [@B22]; [@B4]). This leads to senescence-associated sterile inflammation through the release of inflammatory cytokines, chemokines, matrix degrading enzymes and growth factors, termed senescence-associated secretory phenotype (SASP; [@B24], [@B21]; [@B20]; [@B4]). Senescent cells also secrete damage associated molecular patterns (DAMPs), which are well known inflammatory mediators released from dying cells communicating cellular damage ([@B44]; [@B12]).

Although the senescent signal action is predominantly localized, these signals of cellular stress may get carried to maternal tissues, signaling fetal maturity and prompting delivery of the fetus ([@B28]; [@B46]). Distant senescent signaling is likely facilitated through intercellular signaling vesicles called exosomes ([@B39]). Exosomes are 30--100 nm endosome-derived vesicles with specific characteristics that separate them from other larger particles such as microvesicles and apoptotic bodies ([@B15]; [@B1]). First described as modulators of the immune response to cancer cells, exosomes have also been found to contribute to angiogenesis and metastasis ([@B6]; [@B34]). The current research involving exosome signaling in tumorigenesis via immune cell modulation has increased interest in their role in inflammatory disorders, such as asthma, arthritis and inflammatory bowel disease ([@B10]; [@B8]; [@B34]). Since inflammation is an underlying theme in the initiation and progression of labor ([@B40]; [@B13]; [@B20]; [@B43]; [@B33]), it is likely that exosomes play an important role in cell signaling during term labor.

Exosome size facilitates transport between cells and tissues, while their contents, which reflect the functional state of the cell of their origin, may regulate the phenotype of the target cell ([@B30]; [@B17]; [@B27]). Ongoing studies in our laboratory have shown that myometrial cells treated with exosomes from amnion epithelial cells (AECs) cultured under oxidative stress conditions induce a contractile phenotype through the activation of NFκB and gene transcription activation of contraction associated proteins COX-2 and Connexin 43.

Although studies show exosomes can induce functional changes in myometrial cells, we do not know if the fetal membrane-derived exosomes can reach the maternal tissues to induce labor. The objective of this study was to determine the biodistribution of exosomes *in vivo* in pregnant animal models. By injecting fluorescently labeled amnion cell-derived exosomes into the amniotic fluid of pregnant CD-1 mice, we observed the migration of exosomes from the fetal to the maternal tissues.

Materials and Methods {#s1}
=====================

Patient Inclusion Criteria
--------------------------

No subjects were recruited or consented for this study since we used discarded placenta from normal term, not-in-labor cesarean sections that were de-identified before they were received by lab staff, as described previously ([@B39]). Placental samples obtained for this study were from the John Sealy Hospital at The University of Texas Medical Branch (UTMB) at Galveston, TX, USA. The collection of placenta was approved by the institutional review board at The University of Texas Medical Branch at Galveston in compliance with all applicable Federal regulations governing the protection of human subjects (\#11-251 April 2013). This protocol allowed us to collect discarded placental specimens after normal term cesarean deliveries or vaginal deliveries as an exempt protocol that does not require subject's consent.

Isolation and Culture of Human Amnion Epithelial Cells (AECs)
-------------------------------------------------------------

All reagents and media were warmed to 37°C prior to use. The amniotic membrane was processed within 15 min after delivery as described previously ([@B47]; [@B24]; [@B39]). Primary AECs (*n* = 4) were cultured in T75 flasks containing complete media consisting of Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 media (DMEM/F12; Mediatech Inc., Manassas, VA, USA) supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich, St. Louis, MO, USA), 10% Penicillin/Streptomycin (Mediatech Inc.) and 100 μg/mL epidermal growth factor (EGF; Sigma-Aldrich) at 37°C, 5% CO2, and 95% air humidity to 60--65% confluence.

Exosome Isolation
-----------------

Culture media was removed and cells were serum starved for 1 h in DMEM/F12 with 5% pen/strep prior to treatment with exosome-depleted media (DMEM/F12, 5% pen/strep and 10% exosome-depleted FBS) for 48 h. FBS (Sigma-Aldrich) was depleted of exosomes by ultracentrifugation at 100,000 × *g* for 18 h then filter-sterilized with 0.22 μm filter (Millipore, MA, USA) ([@B42]; [@B17]). Culture media were collected and stored at -80°C until exosome isolation. Media was thawed overnight then isolated using differential ultracentrifugation as described previously, ([@B39]) with the following modifications. After the 2 h 100,000 × *g* centrifugation, the supernatant was removed and the exosome pellet was resuspended in PBS. The sample was then split: half was centrifuged for 1 h at 100,000 × *g* while the other half was labeled with DiR. The final pellets were resuspended in cold PBS and stored at -80°C.

Labeling of Exosomes with DiR
-----------------------------

To fluorescently label exosomes for *in vivo* imaging, we resuspended the pellet centrifuged at 100,000 × *g* for 2 h in 7.0 mL 7.5 μM DiR (Life Technologies, Carlsbad, CA, USA) in PBS. After mixing, the exosomes were incubated in the DiR/PBS solution for 15 min at room temperature in the dark and then ultracentrifuged at 100,000 × g for 1 h. The final pellet was resuspended in 50 μL PBS and stored at -80°C.

Exosome Characterization Using Transmission Electron Microscopy (TEM) and Western Blot
--------------------------------------------------------------------------------------

To show that exosomes isolated from primary AECs exhibit classic exosome shape and morphology, Transmission Electron Microscopy (TEM) studies were performed as described previously ([@B39]), with the following modification: exosomes were fixed in 5% buffered formalin; then, 5 μL of exosome suspension were dropped onto the grid and left to dry at room temperature for 10 min. To show exosome and amnion cell markers, we performed a Western blot as described previously ([@B39]).

Animals
-------

All animal procedures were approved by the Animal Care and Use Committee of Johns Hopkins University. Timed-pregnant CD-1 mice, outbred mice reflecting diverse genetic backgrounds in humans, were purchased from Charles River Laboratories (Houston, TX, USA) and received on gestational day 9 (E9). Animals had access to food and water *ad libitum* freely during housing and the experimental period. To determine the biodistribution of exosomes *in vivo*, we anesthetized pregnant CD-1 mice on E16 (*n* = 9) and E17 (*n* = 9) with continuous isoflurane in oxygen and performed intrauterine injections of DiR-labeled exosomes or phosphate-buffered saline solution (PBS).

Mice were subjected to mini-laparotomy, as illustrated in **Figure [1](#F1){ref-type="fig"}**. Using a Hamilton syringe, saline (*n* = 3 per gestational day) or DiR-labeled exosomes in PBS (*n* = 6 per gestational day) were injected intra-amniotically into each gestational sac on the right side of the cervix (maximum of five injections). The left side of the uterus was not injected and served as an internal control. Surgical incisions were closed, and the dams recovered in individual cages.

![**Illustration of exosomes injected into the amniotic cavity of pregnant mice**.](fphar-07-00432-g001){#F1}

After 24 h, animals were imaged under anesthesia on both the dorsal (after hair removal) and abdominal sides using the Bruker In Vivo MS FX PRO Imager (Bruker, Billerica, MA, USA). Upon completion of live imaging, the animals were sacrificed by carbon dioxide inhalation according to the IACUC and American Veterinary Medical Association guidelines. The fetus contained within the uterus was collected in 4% paraformaldehyde (Sigma-Aldrich) and analyzed by histology for the presence of exosomes. Uteruses were also removed from saline- and exosome-injected mice and imaged using IVIS 200 (PerkinElmer, Inc., Waltham, MA, USA). Any image modifications (brightness, contrast, and smoothing) were applied to the entire image using Image J (open source). Maternal plasma was collected for exosome isolation.

Embryos were removed and fixed in 4% PFA at 4°C overnight. The next day, specimens were washed with PBS extensively and immersed in 30% sucrose until saturation, followed by cryosection at a 20-μm thickness. All photographs were taken with Zeiss AxioPlan 2 Microscope System (Jena, Germany). Routine hematoxylin and eosin (H&E) histochemical staining were performed on the neighbor sections.

Maternal Plasma Exosome Isolation to Localize Trafficking of Exosomes
---------------------------------------------------------------------

To determine whether exosomes injected into the amniotic cavity can reach the maternal side via the systemic route, we analyzed serum samples for fluorescently labeled exosomes in maternal serum. Due to the low volume of serum collected, samples were pooled prior to isolation. Exosomes were isolated from maternal plasma, as described above, and the final pellet was resuspended in 100 μL 1:1 glycerol/ethanol solution. To determine if the isolated exosomes contained fluorescence, we pipetted 50 μL of each sample and control in duplicate into a black 96-well plate (Corning) and imaged them on the Biotek Synergy H4 Hybrid (Biotek, Winooski, VT, USA). Wavelength was set for excitation at 745 nm and emission at 779 nm. A serial dilution of DiR in 1:1 glycerol/ethanol solution was used as the positive control, while the glycerol/ethanol solution was used as a negative control. Values were determined using relative fluorescence units (RFU). Upper and lower limits were established by DiR serial dilution (positive control, RFU \> 50) and the glycerol/ethanol solution (negative control, RFU \< 50). Statistical analysis was not performed as we analyzed pooled sample sets (*n* = 2 in each group) and therefore we report a fold change between the two groups.

Results
=======

Amnion Epithelial Cell-Derived Exosome Characterization
-------------------------------------------------------

Isolated exosomes were characterized using TEM and Western blot for exosome and amnion markers as described previously ([@B39]). TEM analysis revealed vesicles with classic exosome size and morphology (**Figure [2A](#F2){ref-type="fig"}**), consistent with previously published reports for exosomes ([@B32]; [@B18]; [@B37]; [@B26]). Western blot analysis was performed to determine exosome-enriched markers HSC70, CD81, and HSP70, as well as embryonic stem cell marker Nanog (**Figure [2B](#F2){ref-type="fig"}**).

![**Characterization of two representative exosome samples isolated from primary amnion cells.** **(A)** Electron microscopy showing cup-shaped vesicles that have a size distribution of 30--100 nm (arrow indicates exosomes; scale bar represents 100 nm). **(B)** Western blot analysis showing the presence of exosome markers HSC70, CD81 and HSP70, as well as embryonic stem cell marker, Nanog, indicating amnion epithelial cell origin.](fphar-07-00432-g002){#F2}

Exosome Trafficking in Pregnant Mice
------------------------------------

To determine the trafficking of exosomes injected into the amniotic cavity, we imaged animals 24 h after injection. As a negative control, saline was injected into the amniotic cavity and imaged after 24 h. Fluorescent signals could not be seen in saline-injected mice when imaged (data not shown).

Fluorescently labeled exosomes were injected into mice and imaged after 24 h. Regardless of the gestational day, exosome-injected mouse images showed fluorescence on the dorsal side (**Figure [3A](#F3){ref-type="fig"}**), although the signal remained on the injected side. When uteruses were removed and imaged (**Figure [3B](#F3){ref-type="fig"}**), fluorescent signals were seen only on the injected sides and not on the uninjected sides, confirming the dye stays contained within the exosomes and does not leak from the membrane of the exosomes. On gestational day 18, images of the maternal kidneys from saline- and exosome-injected mice were also taken (**Figure [3C](#F3){ref-type="fig"}**). Fluorescent signals were not seen in the saline-injected kidneys, but fluorescence was seen in the kidneys of the exosome-injected mice.

![***In vivo* imaging of pregnant mouse 24 h post injection.** Exosomes stained with DiR (red) were injected into five different embryonic sacs on one side of the uterus. **(A)** Dorsal image after removal of hair using Nair. **(B)** Uterus was removed post sacrifice. Red fluorescence indicated embryonic localization of DiR labeled exosomes. Uninjected side (right) lacks fluorescence. **(C)** Kidneys from saline-injected mice (top) do not have fluorescent signal while kidneys from exosome injected mice (bottom) have fluorescent signal. Merge is an overlay of reflectance and DiR.](fphar-07-00432-g003){#F3}

Histologic analyses of placental and uterine tissues were performed to observe exosome trafficking in the reproductive tissues. On E17, the collected exosome- and saline-injected mouse placentas showed no signals (**Figure [4](#F4){ref-type="fig"}**); however, on E18, signals emerging from exosomes can be seen on the maternal side of the placentas, whereas signals were not seen on the fetal side or in the saline-injected placentas (**Figure [5](#F5){ref-type="fig"}**). *In vivo* imaging of the uterine tissue showed saline-injected uterine tissue did not have fluorescent signals, whereas uterine tissues from the exosome-injected animals showed fluorescent signals (**Figure [6](#F6){ref-type="fig"}**). Fluorescent signals were validated using the Biotek Synergy H4 Hybrid, in which the exosome-injected uterine tissues on day 18 had sixfold higher RFU than the saline-injected tissues (data not shown).

![**Maternal and fetal sides of the placenta collected from injected mice on gestational day 17.** **(A,B)** Lack of fluorescence in saline and exosome injected mouse placenta on either maternal or fetal sides. **(C)** H&E staining of maternal and fetal sides of the placenta (scale bars represent 100 μm). Arrows indicate regions of the placenta.](fphar-07-00432-g004){#F4}

![**Maternal and fetal sides of the placenta collected from injected mice on gestational day 18.** **(A)** Saline injected mouse placenta showed no fluorescence on maternal or fetal sides. **(B)** Exosome injected mouse placenta showed fluorescence on maternal side but lacks signal on the fetal side of the placenta. **(C)** H&E staining of maternal and fetal sides of the placenta (scale bars represent 100 μm).](fphar-07-00432-g005){#F5}

![***In vivo* imaging of uterine tissues collected from gestational day 18.** **(A)** Saline-injected (top) mouse uterus showed no fluorescent signal, while exosome-injected (bottom) mouse uterus showed fluorescence, indicating exosomes traffic to the maternal tissues. **(B)** H&E staining of uterus tissue from saline (left) and exosome (right) injected mice (scale bars represent 100 m). Merge is an overlay of reflectance and DiR.](fphar-07-00432-g006){#F6}

Exosomes Traffic to the Maternal Serum
--------------------------------------

To validate the observations above and trafficking of exosomes through a systemic route, we analyzed exosomes isolated from maternal serum for fluorescence. Exosome injection solution was also analyzed for fluorescence to ensure exosomes were successfully labeled. Serum from saline-injected mice on E17 and E18, as well as from mice injected with exosomes on E17, had an RFU below 50, similar to the negative control (glycerol/ethanol solution). The serum from the exosome-injected mice on day 18 had an RFU above 50, indicating the exosomes from the amniotic fluid can traffic through the maternal serum later in pregnancy and may be dependent on timing. We report a 2.3-fold higher RFU in the serum of animals injected with DiR labeled exosomes compared to saline controls.

In summary, we demonstrated that exosomes may diffuse to the placental side where they can reach maternal tissues through a systemic route.

Discussion
==========

It is generally considered that the timing and initiation of labor are well orchestrated by communications between the fetus and the mother ([@B41]; [@B7]). However, how these signals are communicated between the fetal and maternal compartments is poorly understood. As intercellular signaling vesicles that can travel long distances through tissues and fluids ([@B31]; [@B25]; [@B2]; [@B9]), exosomes may be carriers of these signals.

This study was performed to observe exosome trafficking *in vivo*. After labeling exosomes with the near-infrared dye DiR, we determined that exosomes injected intra-amniotically into pregnant mice can be imaged and monitored for their migration. DiR-labeled exosomes injected on E17 were observed in the maternal plasma and kidneys and on the maternal side of the placenta and uterus on E18, indicating migration from the amniotic cavity to the maternal side. Our study shows that exosomes, which potentially carry signals for the initiation of parturition, can traffic from the amniotic fluid into the placenta and systemically spread through circulation.

Exosomes are characterized by their contents, which reflect the physiological status of the origin cell and can regulate the phenotype of the target cell ([@B16]; [@B2]; [@B39]; [@B45]). At term, oxidative stress and inflammation build up in the amniotic cavity, causing cellular senescence of the fetal membranes and subsequent release of signals of cellular damage ([@B20]; [@B4], [@B3]; [@B29]; [@B22]). Senescent signal action is primarily localized, although we have shown signals of cellular damage are also packaged into exosomes from AECs treated with the oxidative stress inducer cigarette smoke extract ([@B39]). It is likely that exosomes carrying signals of cellular damage can reach maternal tissues and contribute to parturition.

Though our study answers basic questions about exosome trafficking *in vivo*, it does not include activation of inflammatory pathways involved in the initiation and progression of labor. We only allowed for 24 h prior to imaging and tissue collection, which may not be sufficient time for exosomes to migrate to the target tissues or cause functional changes. Determination of initiation of parturition at term or preterm based on signals carried by exosomes was beyond the scope of this study. Exosomes were stored at -80°C until the day of injection. Although the stability of amnion epithelial cell-derived exosomes during freeze-thaw cycles has been not been evaluated for this study, there have been published reports demonstrating exosome stability in various biological fluids from pregnancy ([@B38]). The number of exosomes injected was random, which may have an effect on the trafficking and eventual response to exosome signaling. Our ongoing studies using a specific number of exosomes will determine the effect of the quantity required to cause a functional change and specific pregnancy outcomes like preterm or term parturition. Future studies using live imaging will also determine the timing required for exosome migration between feto-maternal compartments. We will also understand differences between exosomes from amnion cells grown under standard conditions and oxidative stress conditions, including activation of inflammatory pathways related to parturition and preterm birth rates.

In summary, we have demonstrated that exosomes injected into the amniotic cavity of pregnant mice can traffic to the maternal tissues. Specifically, exosomes injected on gestational day 17 migrated to the maternal side of the placenta, the maternal serum, and the maternal kidneys. So we propose that exosomes can traverse through various tissue layers and or it can reach various tissues through a systemic route. Although not tested, the diffusion of exosomes through various layers could be a concentration dependent process and the quantity very well may determine the fetal signal strength. Oxidative stress is expected to increase exosome numbers ([@B36]) and at term, oxidative stress induced increased production of exosomes from fetal tissues may increase exosome quantity and thus signal strength. This study demonstrated that fetal signals can be carried as exosomal cargo through either diffusion between tissues or through systemic route from the fetal to the maternal side during pregnancy. This supports the postulate that fetal signals that can contribute to the initiation of human parturition can be delivered via exosomes.

Author Contributions
====================

RM and IB conceived and designed the experiments. SS-M and JL performed the experiments. RM, SS-M, and JL analyzed the data. RM, IB, GS, and CS contributed reagents/materials/analysis tools. RM, SS-M, JL, and IB wrote the paper.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This study was partly supported by an Innovative Catalyst Grant from the March of Dimes Prematurity Research Center Ohio Collaborative awarded to RM.

The authors acknowledge support by the staff from the Maternal-Fetal Medicine and Perinatal Research Laboratory at the University of Texas Medical Branch in Galveston, TX, USA. We specifically wish to thank Lauren Richardson for her expertise in image creation and Jason Rosenzweig, PhD, for his assistance on injections, imaging, and necropsies at Johns Hopkins University. *In vivo* imaging at the biomedical imaging core at UTMB was performed with the support and guidance from Igor Patrikeev, PhD.

[^1]: Edited by: *Ronald James Wong, Stanford University, USA*

[^2]: Reviewed by: *Surendra Sharma, Women & Infants Hospital of Rhode Island, USA; Maide Ozen, Brigham and Women's Hospital, USA*

[^3]: This article was submitted to Obstetric and Pediatric Pharmacology, a section of the journal Frontiers in Pharmacology
